CN109884309A - Enterobacteriaceae polypeptide, antibody capture device and kit - Google Patents

Enterobacteriaceae polypeptide, antibody capture device and kit Download PDF

Info

Publication number
CN109884309A
CN109884309A CN201711500427.8A CN201711500427A CN109884309A CN 109884309 A CN109884309 A CN 109884309A CN 201711500427 A CN201711500427 A CN 201711500427A CN 109884309 A CN109884309 A CN 109884309A
Authority
CN
China
Prior art keywords
seq
polypeptide
antibody
enterobacteriaceae
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201711500427.8A
Other languages
Chinese (zh)
Other versions
CN109884309B (en
Inventor
李振军
陈菲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Sharp Biotechnology Co Ltd
Original Assignee
Suzhou Sharp Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Sharp Biotechnology Co Ltd filed Critical Suzhou Sharp Biotechnology Co Ltd
Priority to CN201711500427.8A priority Critical patent/CN109884309B/en
Publication of CN109884309A publication Critical patent/CN109884309A/en
Application granted granted Critical
Publication of CN109884309B publication Critical patent/CN109884309B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The present invention discloses core sequence, the enterobacteriaceae polypeptide containing core sequence, antibody capture device, kit and the detection method of enterobacteriaceae polypeptide shown in a kind of SEQ ID:1, belongs to immunological technique field.The technical scheme is that clonal expression contains the enterobacteriaceae polypeptide of SEQ ID:1 core sequence, the antibody in the polypeptide capture sample containing core sequence, has the function that auxiliary diagnosis Crohn disease by solid phase carrier and thereon.

Description

Enterobacteriaceae polypeptide, antibody capture device and kit
Technical field
The present invention relates to a kind of core sequences of enterobacteriaceae polypeptide, and it includes the antibody capture device and kit of polypeptide, Belong to technical field of immunological detection.
Background technique
Inflammatory bowel disease (inflammatory bowel disease, IBD) is a kind of autoimmune enteropathy, including is burst Ulcer colitis (ulcerative colitis, UC) and Crohn disease (Crohn ' s disease, CD), exist during the nearly last ten years China's disease incidence is in gradually to increase trend.The complicated clinical manifestation multiplicity of IBD, not only has symptom of digestive tract, can also there is parenteral table It is existing.Since symptom is the non-specific enteritis performance such as abdominal pain, diarrhea, hematochezia, CD and UC and IBD and tuberculous enteritis etc. its He is difficult to discriminate between diagnosis at enteron aisle chronic disease.Serological index helps to identify CD and UC and IBD and non-IBD.
The pathogenesis of IBD is complicated, and the mechanism of one of them is to make intestinal mucosa since the factors such as heredity, environment influence Barrier dysfunction, immune system is immunoreacted antigenic product existing for normal bowel, shows as can be detected in vivo pair The antibody of enteric microorganism antigen and metabolin.It, can auxiliary diagnosis autoimmunity enteropathy packet by the detection to these antibody Include IBD.At present explicitly with the effect of IBD auxiliary diagnosis antimicrobial antibody include anti-CBirl antibody, anti-Fla-X resist The bacterial flagellums antibody such as body, anti-4aFla-2 antibody and anti-Pseudomonas fluorescens I2 antibody and anti-Escherichia coli outer membrane duct Albumen OmpC antibody etc..Due to the easy variability and polymorphism of microbial gene, new microbial antigen is continuously emerged, wherein Some immunological regulations for participating in intestinal mucosa.The IBD related antigen of enterobacteriaceae polypeptide and existing report that the present invention is announced is more Peptide significant difference, but analyzed by sequence, it is certain core sequences that discovery generates related with enterobacteriaceae polypeptide autoantibody, is contained There is the enterobacteriaceae polypeptide of the core sequence to verify through the clinical samples of clinical definite, there is the energy for identifying Healthy People and Crohn disease Power.
Summary of the invention
The first aspect of the present invention announces enterobacteriaceae polypeptide and core sequence shown in SEQ ID:1, connects core sequence Between amino acid sequence can there are many variation.
In one preference, the polypeptide includes three core sequences, is shown in SEQ ID:2.
In another preference, the polypeptide includes two of them core sequence, is shown in SEQ ID:3 and SEQ ID:4.
The second aspect of the present invention provides a kind of preparation method of antibody capture device, and the enterobacteriaceae polypeptide is straight It connects or is indirectly fixed on solid phase carrier, for capturing the anti-enteron aisle bacteria antibody in sample.
Solid phase carrier includes microwell plate, fluorescent microsphere, latex beads, resin microsphere, magnetic microsphere, film, microporous barrier, nitre Acid cellulose film etc..
In one preference, solid phase carrier is microwell plate, is magnetic microsphere in another preference, in the 3rd preference Fluorescent microsphere and nitrocellulose membrane have been selected simultaneously, are colloidal gold in the 4th preference.
The method that polypeptide is fixed on solid phase carrier is direct coated or is coated with indirectly by carrier protein, it is preferable that carrier Albumen is BSA or biotin-streptavidin.
In one preference, the polypeptide and BSA are coupled, are then coated on solid phase carrier again.
In another preference, first polypeptide and biotin reaction, then biotinylated polypeptide and Streptavidin Coupling, forms the compound of polypeptide and streptavidin, then compound is coated on solid phase carrier.
The third aspect of the present invention discloses the kit being made of antibody capture device above-mentioned and in diagnosis of Crohn disease In application, application of the present invention be based on immunological response, to the measuring method of enteron aisle bacteria antibody anti-in sample, including Following steps: (1) sample to be detected acts on antibody capture device, makes anti-enteron aisle bacteria antibody and antibody capture device in sample On polypeptide combine;(2) pass through the content of anti-enterobacteriaceae polypeptide antibody in marker measurement sample.
Enterobacteriaceae antigen or epitope conjugate can be detected in sample by current any immunological detection method Anti- enteron aisle bacteria antibody, such as ELISA, board-like chemiluminescence, chemiluminescence, immunochromatography, immunity percolation etc. are corresponding Marker is respectively horseradish peroxidase, alkaline phosphatase, acridinium ester, rare earth element and colloidal gold etc..
Embodiment 4 provides the board-like detection method of enzymatic of two kinds of anti-enteron aisle bacteria antibodies, and enterobacteriaceae polypeptide is coated on microwell plate On, antigen-antibody complex is formed with the antibody response in sample, anti-human igg and IgA enzyme are marked, enzyme used is horseradish Peroxidase and alkaline phosphatase, sample used are excrement and urine.
Embodiment 5 provides a kind of chemical luminescence detection method of acridinium ester label, after the enterobacteriaceae polypeptide biotinylation By being coated on magnetic microsphere with streptavidin, antigen antibody complex is formed with the antibody response to be checked in plasma sample, Quantitative detection is carried out to antigen antibody complex with the anti-human antibody of acridinium ester label after cleaning.The detection method has sensitivity High, the advantages that detection time is short, full-automatic detection.
Embodiment 6 provides a kind of fluorescence immune chromatography method of anti-enterobacteriaceae polypeptide antibody, and the method is enterobacteriaceae Polypeptide is coated with directly or by biotin-streptavidin onto the fluorescent microsphere containing rare earth element, while polypeptide coating to inspection On survey line T line, the anti-enterobacteriaceae antibody content in dual-antigen sandwich method detection serum sample is formed.The detection method has fast Speed, the advantages that detection time is short, high sensitivity.
Embodiment 7 provides a kind of colloidal gold of anti-enterobacteriaceae polypeptide antibody or color latex chromatography method, the method are Enterobacteriaceae polypeptide colloid gold particle or color latex microballoon are marked, are sprayed in sample pad, while polypeptide is coated on detection On line T line, anti-enterobacteriaceae polypeptide antibody in dual-antigen sandwich method detection whole blood sample is formed.The detection method can visually observe knot Fruit has many advantages, such as that quick, instrument cost is small.
Compared with prior art, enterobacteriaceae polypeptide and antibody capture device provided by the invention, when being used for Crohn disease, tool There are high sensitivity, performance stabilization, simple operation and other advantages.
Detailed description of the invention
Fig. 1 chemiluminescence quantitative measurement standard curve
The specificity and sensitivity of Fig. 2 chemiluminescence quantitative detection
Fig. 3 fluorescence immune chromatography reagent standard curve
Specific embodiment
Biotin used in the present invention, goat anti-human igg, goat-anti people IgA are purchased from Sigma and Abcam.Avidin is purchased from Pan Gu Gene.Magnetic microsphere and the pre-coated magnetic microsphere for having Streptavidin are purchased from Nanjing enlightening Gneuss.Microwell plate is purchased from Su Zhouhai Leopard cat.Latex beads, color latex microballoon, resin microsphere are purchased from Tianjin Sai Er groups.Rare earth element fluorescent microsphere and time resolution are glimmering Optical reader is purchased from Shenzhen micrometering.Other reagents are purchased from the raw work of traditional Chinese medicines reagent and Shanghai.
Combined with specific embodiments below and attached drawing, the present invention is further explained.
The preparation of 1 enterobacteriaceae polypeptide of embodiment
1, SEQ ID:2, SEQ ID:3 and the preparation of SEQ ID:4 polypeptide
SEQ ID:2, SEQ ID:3 and SEQ ID:4 whole genome sequence are synthesized by Jin Weizhi.
1) reagent
Cloning vector pCR2.1 T-vector, expression plasmid pET28a (+), transfection Escherichia coli host strain DH5 α, BL21 (DE3), archaeal dna polymerase rTaq, T4DNA ligase, archaeal dna polymerase rTaq, LA Taq and restriction enzyme BamH I, Hind III and EcoR I, BamH I, DL2000DNA Marker, T4DNA ligase, low molecular weight standard protein, DNA glue return Receive kit, IPTG etc.
2) instrument
Common shaking table SCS-24;Water isolation type constant temperature electric heating incubator;Biophotometer spectrophotometer, desk-top freezing Centrifuge Centrifuge5810R, desk centrifuge MiniSpin;High speed freezing centrifuge;Protein electrophorese instrument and gel Imaging system;PCR instrument;Ultrasound cracking instrument;Constant-temperature metal bath;HIS protein purification column etc..
2. experimental method
1) vector construction:
Design primer, PCR amplification goes out SEQ ID:2, SEQ ID:3 and SEQ ID:4 segment, glue recycling examination from template DNA PCR2.1 cloning vector, which is connected to, after agent box recycling segment carries out sequencing identification.It will identify that correct sequence is cloned into expression vector In pET28a (+), restriction enzyme site is EcoR I, BamH I, while having 6 × HIS label on carrier, pure convenient for subsequent albumen Change.
2) it expresses
Obtained plasmid is converted to e. coli bl21 (DE3), resistance screening positive expression bacterial strain is passed through.It will filter out The positive bacterium solution come is inoculated in the LB culture medium added with Kan resistance in 1: 1000 ratio, and each two pipe of bacterium inoculation a, pipe is used for Induction, another pipe is used for non-induced control, while to be inoculated with a pipe empty plasmid bacterium and compare.37 DEG C are incubated overnight to OD600 value When about 0.4-0.6, IPTG to final concentration of 1mmol/L is added in induction pipe and empty control plasmid pipe, and non-induced control is not added, most Two high bacterium of selection ability to express eventually, the expression for a large amount of albumen.And according to conventional SDS-PAGE method to expression Product is identified.
3) it purifies
By the product of expression HIS protein purification column purification albumen, and dialysis desalting, SEQ ID:2, SEQ after purification ID:3 and SEQ ID:4 cryo-conservation is spare.
Embodiment 2 prepares anti-enterobacteriaceae polypeptide antibody
1. animal immune
Mouse is immunized with SEQ ID:2, SEQ ID:3 and SEQ ID:4 respectively, immunizing dose is 50 μ g/.It generates positive After serum, booster immunization once carries out cell fusion afterwards.
Such as need to prepare polyclonal antibody, can same method immune goat or rabbit, take serum obtain polyclonal antibody.
2. cell fusion
PEG1500 pre-temperature draws 1 × 107A SP2/0 myeloma cell's suspension and 5 × 107It is a it is immune after mouse spleen B Lymphocyte suspension (cell number 1: 5) is merged with the 50%PEG1500 solution of pre-temperature, and supernatant is abandoned in centrifugation, and 10ml HAT is added (SIGMA) cell is resuspended in culture medium, is seeded to and has been covered with 96 porocyte culture plates of trophocyte and is cultivated.
3. screening and clone
After fused cell culture 10-14 days, sieved with SEQ ID:2, SEQ ID:3 or SEQ ID:4 coating microwell plate Choosing, positive hole carry out limiting dilution, are then further cultured for 10~14 days, 3~4 times repeatedly, it is thin to obtain anti-SEQ ID:2 monoclonal antibody Born of the same parents' strain, anti-SEQ ID:3 monoclonal antibody cell strain and anti-SEQ ID:4 monoclonal antibody cell strain.
4. prepared by ascites
Ascites is collected after mouse ascites accumulation in monoclonal cell Mice Inoculated abdominal cavity.By ascites under the conditions of 4 DEG C, 10000 revs/min are centrifuged 10 minutes, remove lipid material.Supernatant is drawn after centrifugation, and is filtered with 0.45 μm of film. Protein G is purified.Monoclonal antibody concentration mensuration after purification, dispense, freeze it is spare.
The preparation of the anti-enterobacteriaceae antibody capture device of embodiment 3
1, SEQ ID:2, SEQ ID:3 and SEQ ID:4 are coated with microwell plate
Concentration with phosphate buffered saline SEQ ID:2, SEQ ID:3 and SEQ ID:4 is about 5ug/mL, every hole 100uL is coated with 96 hole microwell plates, and 4 DEG C overnight, discard coating buffer, and board-washing is primary, with the Block buffer for containing 1% calf serum Every hole 200uL, 37 DEG C are incubated for 2 hours, pat dry, are dried for standby.
2, SEQ ID:2, SEQ ID:3 and SEQ ID:4 are coated with magnetic microsphere
Appropriate amino magnetic microsphere is taken, is cleaned and is resuspended with PBS buffer solution, 5% glutaraldehyde solution is added, is stirred at room temperature anti- It answers 1 hour;It is cleaned and is resuspended with PBS buffer solution, after ultrasonic disperse, SEQ ID:2, SEQ is added by 100 μ g/mg magnetic microspheres It is reacted at room temperature 6 hours after ID:3 or SEQ ID:4;It is cleaned and is resuspended with PBS buffer solution, after 1%BSA closing being added 30 minutes, It adds after 1% glycine is closed 30 minutes after being cleaned with PBS buffer solution and is resuspended to get SEQ IID:2 magnetic microsphere, SEQ ID:3 magnetic microsphere and SEQ ID:4 magnetic microsphere.
3, SEQ ID:2, SEQ ID:3 and SEQ ID:4 biotinylation
Biotin, dicyclohexylcarbodiimide (DCC) and n-hydroxysuccinimide (NHS) is taken to be dissolved in DMF, room temperature magnetic Power is stirred to react 3 hours, and supernatant is collected by centrifugation;Supernatant is added dropwise to SEQ ID:2, SEQ ID:3 or SEQ ID:4 In solution, 2-8 DEG C is stirred to react 6 hours;Reaction solution taking-up is dialysed with phosphate buffer, obtains biotinylation SEQ ID: 2, biotinylation SEQ ID:3 and biotinylation SEQ ID:4.
4, SEQ ID:2, SEQ ID:3 and SEQ ID:4 coating fluorescent microsphere and detection line T line
1) fluorescent microsphere, color latex microballoon and resin microsphere label
Take fluorescent microsphere, color latex microballoon or resin microsphere 200 μ l (210nm) (1% stoste), 13000rpm, 4 DEG C from Heart 10min abandons supernatant, and 400ul deionized water ultrasound 10S is added and mixes;Centrifugation is added MES buffer (50mM, PH6.0) 400 μ l, ultrasound mix;EDC solution is added in centrifugation, reacts at room temperature 15 minutes;Labelled antibody (ID:2~4 SEQ are added in centrifugation With rabbit-anti chicken IgY) 100ug, room temperature shaker middling speed is reacted 2 hours;Confining liquid is added in centrifugation, and ice water ultrasound mixes, room temperature shaker Middling speed is reacted 1 hour;Centrifugation, be added 400 μ l borate buffer solutions (20mM PH8.0), ice water ultrasound mix, 4 DEG C save to With.
2) detection line T line is coated with
With phosphate buffer the polypeptide of SEQ ID:2~4 is diluted to 1mg/ml respectively, draws liquid measure by 1 μ l/cm, use metal spraying Film instrument is drawn uniformly to draw to preparation T line on NC film;The NC film pulled is placed in 37 DEG C of drying boxes, dry 16h.
5, SEQ ID:2, SEQ ID:3 and SEQ ID:4 mark colloidal gold
Colloidal gold 10ml is taken, appropriate O.1M K is added2CO3Adjust pH.Appropriate formula SEQ ID:2, SEQ ID are added after mixing: 3 or SEQ ID:4 continues to stir 30min;Be added 10%BSA to its final concentration of 1%, continue stir 30min;10000rpm 4 DEG C of centrifugation 20min, collect precipitating, with colloidal gold dilution (0.2M BB, 1%BSA, 3% trehalose, 0.03% Procline300 it is settled to 1ml) to get SEQ ID:2, SEQ ID:3 and SEQ ID:4 colloidal gold composite.
4 enterobacteriaceae polypeptide of embodiment is used to prepare the board-like detection kit of enzymatic
1, the polypeptide of SEQ ID:2~4 is coated with microwell plate
(1) buffer of SEQ ID:2~4 is diluted to 5 μ g/ml, is coated with onto microwell plate, every hole 100 μ l, 4 DEG C of incubation 16h Or 37 DEG C of incubation 2h.
(2) with PBST washing 3 times, drying;
(3) it is closed with the protein solution containing 1% bovine serum albumin(BSA), 200uL confining liquid is added in every hole, and 37 DEG C anti- 2h is answered, hole inner sealing liquid is discarded, is dried;
(4) coating plate is placed in 37 DEG C of baking oven 4h, that is, completes coating, is sealed with aluminium foil bag, it is standby to deposit in -20 DEG C of preservations With.
2, anti-polypeptide IgG antibody detection
(1) it is added to after diluting 10 healthy human faecal mass and 10 cd patient fecal samples with Sample dilution In the microwell plate being coated with, react at room temperature 1h, board-washing 4 times;
(2) it is added the goat anti-human igg of horseradish peroxidase-labeled, 37 DEG C of reaction 0.5h, board-washing 4 times;
(3) plus horseradish peroxidase substrate develops the color;
(4) it terminates, reading.
3, anti-polypeptide IgA antibody detection
(1) coating is added to after diluting 10 Healthy People urines and 10 cd patient urines with Sample dilution In good microwell plate, 1h is reacted at room temperature, board-washing 4 times;
(2) it is added the goat anti-human igg of alkali phosphatase enzyme mark, 37 DEG C of reaction 0.5h, board-washing 4 times;
(3) plus alkaline phosphatase substrate develops the color;
(4) it terminates, reading.
4, data are analyzed
The mean OD value of 10 Healthy People samples is calculated, 2.5 times of OD value is higher than as negative and positive numerical value is distinguished This value is positive (+), is negative (-) less than or equal to this value, counts the inspection of 10 patient's fecal samples and urine specimen As a result measured data prompts, in the excrement of cd patient the antibody positive rate of the anti-polypeptide of SEQ ID:2~4 be respectively 20%, 20% and 30% (being shown in Table 1);Positive rate in urine specimen is respectively 10%, 10% and 20%.
Testing result of the 1 enterobacteriaceae polypeptide antibody of table in fecal sample
Embodiment 5 is used to prepare acridinium ester label chemiluminescence detection kit
Full-automatic chemiluminescence apparatus and the goat anti-human igg for marking acridinium ester and IgA are by the offer of Nanjing enlightening Gneuss.
The goat anti-human igg and IgA of the pre-coated magnetic microsphere of SA used in this experiment and acridinium ester label are commercial product.
It can be there are two types of different implementation methods:
The first: (1) pressing step 2 method of embodiment 3, the direct coated of SEQ ID:2~4 on magnetic microsphere, this is micro- Ball solution is R1;(2) R2 is goat anti-human igg/IgA antibody of acridinium ester label.Sample to be detected is reacted with R1 when detection, it Magnetic Isolation removes sample impurity afterwards, cleans 3 times, reacts with R2, is formed and contains Ag-Ab-antiantibody sandwich complex, multiple It closes object and carries out acridinium ester quantitative fluorescence analysis.
Second: (1) pressing step 3 method of embodiment 3, the biotinylation of SEQID:2~4, this solution is R1;(2) R2 For the magnetic microsphere of pre-coated SA;(2) R3 is goat anti-human igg/LgA antibody of acridinium ester label.Detect Shi Keyong one-step method or Two step method, the former is for sample sheet, R1 and R2 simultaneous reactions;The latter first reacts SA magnetic microsphere with biotinylated R1, magnetic Property separate and wash after be added for sample sheet.Two methods are equally effective.One-step method or two step method, which are formed, contains Ag-Ab- Antiantibody sandwich complex, compound carry out acridinium ester Quantitative Analysis of Luminescence.
1) standard curve making
The goat anti-human igg of acridinium ester label or IgA antibody are diluted 5 concentration, respectively: the goat-anti people of acridinium ester label IgG and IgA antibody respectively dilute 5 concentration, respectively 0ng/ml, 50ng/ml, 100ng/ml, 200ng/ml, 400ng/ml.With Above-mentioned the first and second detection method make standard curve, and wherein the anti-human igg of second method and IgA standard curve are shown in Fig. 1, R2Value is respectively 0.9981 and 0.9956.
2) pattern detection
100 human normal plasmas or serum and 100 clone grace patients are detected with above-mentioned the first and second method Blood plasma or serum, the sensitivity of two kinds of detection methods with second be it is excellent, wherein the ROC curve of second method detection is shown in Fig. 2. As shown in table 2, the area under the curve of SEQ ID:2, SEQ ID:3 and SEQ ID:4 anti-human igg is respectively 0.702,0.612 and 0.735, when illustrating for diagnosing Crohn disease, the detection sensitivity and specificity of SEQ ID:4 is best, followed by SEQ ID:2 With SEQ ID:3.
The IgG area under the curve of anti-ID:2~4 SEQ of table 2
6 enterobacteriaceae polypeptide of embodiment is used to prepare rare earth element fluorescence immune chromatography detection kit
Antibody standard substance used in this experiment is the anti-SEQ ID:2 monoclonal antibody of 2 method of embodiment preparation, anti-SEQ ID:3 monoclonal antibody And anti-SEQ ID:4 monoclonal antibody.Rabbit-anti chicken IgY is commercial product.The fluorescent microsphere and time-resolved fluorescence of rare earth element label are read It reads device and is purchased from Shenzhen micrometering company.
1, the preparation of fluorescence immune chromatography kit
(1) label of fluorescent microsphere and detection line T line coating
The method of the polypeptide marker fluorescent microsphere of SEQ ID:2~4 is shown in 3 step 4 of embodiment.
(2) preparation of sample pad and bonding pad
Glass fibre element film with containing surfactant buffer (formula: 100mM pH 7.4PB, wherein containing 2% NaCl, 2%BSA, 0.5% casein, 0.1% Tween-20,0.5%S9 and 5% sucrose) impregnate carry out in advance close after, 37 DEG C It is dried overnight, sample pad is prepared;
The sample pad prepared is taken, draws the polypeptide of SEQ ID:2~4 and rabbit-anti that film instrument will be marked with fluorescent microsphere with metal spraying Chicken IgY antibody is sprayed onto the wide sample pad for 1cm of pretreatment according to the amount of 5 μ l/cm, and combination is prepared in 37 DEG C of dry 5h Pad.
(3) coating of nitrocellulose filter (NC film)
With phosphate buffer the polypeptide of SEQ ID:2~4 is diluted to 1mg/ml respectively, is used to prepare T line;Chicken IgY is resisted Body is diluted to 0.5mg/ml, is used to prepare C line;Liquid measure is drawn by 1 μ l/cm, it is uniform by above two solution to draw film instrument with metal spraying It draws to preparation T line and C line on NC film;The NC film pulled is placed in 37 DEG C of drying boxes, dry 16h.
(4) it assembles
The bonding pad that step 2) is obtained is laminated on the one end for the nitrocellulose filter that step 3) obtains, and water absorption pad is consolidated Surely it is laminated on the other end of nitrocellulose filter, the sample pad for finally obtaining step 2) is laminated on the bonding pad other end, and use is micro- The automatic cutting machine of computer is cut by the width of every 5.5mm, and is fitted into chromatography strip shell to get finished product.
2, standard curve
Anti- SEQ ID:2 monoclonal antibody, anti-SEQ ID:3 monoclonal antibody and the anti-SEQ ID:4 monoclonal antibody difference prepared with embodiment 2 is dilute 5 concentration are released, respectively: 0ng/ml, 25ng/ml, 50ng/ml, 100ng/ml, 200ng/ml distinguish the above calibration object of 50 μ l It is added drop-wise on well, is detected after 15 minutes with fluorescence detector, fluorescence can be collected on detection line T and nature controlling line location of C. Quadratic polynomial fitting is carried out with sample concentration and T/C value, draws standard curve, the R of ID:2~4 SEQ2Respectively 0.9940,0.9908 and 0.9993 (see Fig. 3).According to the detection to 200 Healthy Human Serum samples, 90% Healthy People is anti- The cut-off value that the antibody of SEQ ID:2~4 is judged as negative is 30ng/ml, 35ng/ml and 30ng/ml respectively.
3. sample detection
The blood sample to be checked for taking 50 μ l, is added drop-wise on well, is detected after 15 minutes with fluorescence detector, if detection line goes out Existing band illustrates that, containing anti-enterobacteriaceae polypeptide antibody in sample, content can the acquisition of establishing criteria curve calculation formula.20 samples Testing result to be shown in Table the detection specificity of ID:2~4 3, SEQ be respectively 80%, 80% and 90%, sensitivity is respectively 50%, 40% and 50%.
3 fluorescence immune chromatography test result of table
7 enterobacteriaceae polypeptide of embodiment is used to prepare gold calibration property detection kit
1, the gold marked reagent blocking of SEQ ID:2~4 is standby
1) preparation of colloidal gold
In round-bottomed flask be added 0.01% chlorauric acid solution of 100ml, be placed in and be heated to boiling on electric jacket, at once plus Enter 1% citric acid three sodium solution of 2ml, continues to stir 15min, be saved backup for 4 DEG C after natural cooling.
2) colloid gold label
See 3 step 5 of embodiment.
3) preparation of sample pad and gold-labelled pad
Glass fibre element film with treatment fluid liquid (formula: 100mM pH 7.4PB, wherein contain 2%BSA, 0.5% tween- 20,0.5%S9 and 5% sucrose) impregnate carry out in advance close after, 37 DEG C are dried overnight, and sample pad is prepared;
The sample pad prepared is taken, draws the gold that film instrument will be marked with SEQ ID:2, SEQ ID:3 and SEQ ID:4 with metal spraying The gold mark compound of mark compound and rabbit-anti chicken IgY antibody label is sprayed onto the wide sample for 1cm of pretreatment according to the amount of 5 μ l/cm On product pad, gold-labelled pad is prepared in 37 DEG C of dry 5h.
4) coating of nitrocellulose filter (NC film)
SEQ ID:2, SEQ ID:3 and SEQ ID:4 polypeptide are diluted to 1mg/ml with phosphate buffer, are used to prepare T Line;Chicken IgY antibody is diluted to 0.5mg/ml, is used to prepare C line;Liquid measure is drawn by 1 μ l/cm, draws film instrument for above-mentioned two with metal spraying Kind solution is uniformly drawn to preparation T line and C line on NC film;The NC film pulled is placed in 37 DEG C of drying boxes, dry 16h.
5) it assembles
The auxiliary materials such as above-mentioned gold-labelled pad, sample pad, the NC film being coated with and water absorption pad are assembled into gold-labeled kit.
2, kit detects
(1) detection method
Sampling originally to take 100 μ l after Sample dilution (BB, 0.5%s9,1%BSA) dilution, is directly added into sample in chromatography strip Product window;After 15min, Visual observations.
(2) result judgement
Negative findings (-): only there is nature controlling line, no detection line;
Positive findings (+): nature controlling line occurs simultaneously with detection line;
Null result: nature controlling line does not occur, and shows operating mistake or kit failure.
(3) it detects
The standard items and 20 whole blood samples for taking 100 μ l embodiments 5 to prepare are separately added into sample window in chromatography strip; After 15min, Visual observations (table 4), ID:2~4 SEQ are for judging that the specificity of Crohn disease is respectively 80%, 80% With 90%, sensitivity is respectively 40%, 30% and 50%.
4 gold marked reagent test result of table

Claims (7)

1. enterobacteriaceae polypeptide shown in a kind of SEQ ID:1, which is characterized in that include 3 core sequences and catenation sequence xxx.
2. enterobacteriaceae polypeptide described in claim 1, which is characterized in that catenation sequence xxx can make a variation, it is preferable that be SEQ ID: 2, SEQ ID:3 or SEQ ID:4 polypeptide.
3. a kind of antibody capture device, which is characterized in that enteron aisle described in solid phase carrier and thereon coated claim 1~2 Bacterium polypeptide.
4. solid phase carrier as claimed in claim 3, which is characterized in that including but not limited to fluorescent microsphere, latex beads, resin are micro- Ball, magnetic microsphere, colloid gold particle, microwell plate, film, microporous barrier, nitrocellulose filter.
5. a kind of Crohn disease detection kit and method, which is characterized in that including described in claim 1~2 polypeptide or Antibody capture device described in claim 3~4, method comprising steps of
(1) sample is acted on into antibody capture device;
(2) pass through the content of anti-enterobacteriaceae polypeptide antibody in marker measurement sample.
6. sample described in claim 5, which is characterized in that serum, blood plasma, whole blood, urine or excrement.
7. marker described in claim 5, which is characterized in that include but is not limited to horseradish peroxidase, alkaline phosphatase, Acridinium ester, rare earth element, colloidal gold, color latex.
CN201711500427.8A 2017-12-25 2017-12-25 Intestinal bacteria polypeptide, antibody capture device and kit Active CN109884309B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711500427.8A CN109884309B (en) 2017-12-25 2017-12-25 Intestinal bacteria polypeptide, antibody capture device and kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711500427.8A CN109884309B (en) 2017-12-25 2017-12-25 Intestinal bacteria polypeptide, antibody capture device and kit

Publications (2)

Publication Number Publication Date
CN109884309A true CN109884309A (en) 2019-06-14
CN109884309B CN109884309B (en) 2022-07-05

Family

ID=66924733

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711500427.8A Active CN109884309B (en) 2017-12-25 2017-12-25 Intestinal bacteria polypeptide, antibody capture device and kit

Country Status (1)

Country Link
CN (1) CN109884309B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110212104A1 (en) * 2008-11-03 2011-09-01 Schering Corporation Inflammatory bowel disease biomarkers and related methods of treatment
CN104297488A (en) * 2014-08-20 2015-01-21 苏州和锐医药科技有限公司 Anti-CBir1 antibody detection test paper preparation method and purpose thereof
CN104297465A (en) * 2014-08-20 2015-01-21 苏州和锐医药科技有限公司 Anti-OmpC antibody detection test paper preparation method and purpose thereof
CN104764882A (en) * 2014-08-20 2015-07-08 苏州和锐医药科技有限公司 Preparation method and application of anti-BPI-ANCA antibody test strip
CN107290539A (en) * 2017-06-07 2017-10-24 哈尔滨医科大学 Peptide composition and its application for detecting Serum of Patients With Autoimmune Diseases blood serum designated object

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110212104A1 (en) * 2008-11-03 2011-09-01 Schering Corporation Inflammatory bowel disease biomarkers and related methods of treatment
CN104297488A (en) * 2014-08-20 2015-01-21 苏州和锐医药科技有限公司 Anti-CBir1 antibody detection test paper preparation method and purpose thereof
CN104297465A (en) * 2014-08-20 2015-01-21 苏州和锐医药科技有限公司 Anti-OmpC antibody detection test paper preparation method and purpose thereof
CN104764882A (en) * 2014-08-20 2015-07-08 苏州和锐医药科技有限公司 Preparation method and application of anti-BPI-ANCA antibody test strip
CN107290539A (en) * 2017-06-07 2017-10-24 哈尔滨医科大学 Peptide composition and its application for detecting Serum of Patients With Autoimmune Diseases blood serum designated object

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GIUSEPPE MANCUSO 等: ""Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4"", 《INFECT IMMUN》 *
张小斌 等: ""血清抗微生物抗体检测在炎症性肠病中的应用价值"", 《现代医药卫生》 *

Also Published As

Publication number Publication date
CN109884309B (en) 2022-07-05

Similar Documents

Publication Publication Date Title
AU2010200492B2 (en) Method and device for trichomonas detection
JP6637114B2 (en) Immunological detection method and kit for Mycoplasma pneumoniae
JP2021167805A (en) Methods and Reagents for Diagnosing SARS-CoV-2 Infection
CN105683756B (en) The assay method of influenza B virus
NO321090B1 (en) Method for detecting the presence of perinuclear, antinoytrophilic, cytoplasmic antibody (p-ANC) associated with type 1 autoimmune hepatitis and primes, sclerosing cholangitis in a sample and method for separating primers, sclerosing cholangitis from type 1 autoimmune hepatitis.
JP7175147B2 (en) Immunological detection method and kit for Mycoplasma pneumoniae
JP2006284567A (en) Diagnostic method and kit for helicobacter pylori infection
JP7178224B2 (en) Immunological detection method and kit for Mycoplasma pneumoniae
WO2005042579A1 (en) Anti-sars virus antibody, hybridoma producing the antibody and immunoassay reagent using the antibody
CN109884308A (en) Mannocarolose haptens, conjugate and application
US20150276739A1 (en) Soluble treponema pallidum protein tp0453, tp0453-tp0326 fusion protein, and use in syphilis diagnosis
JP5204036B2 (en) Method for detecting pneumococci
CN109879940A (en) Flagellum G polypeptide, antibody capture device and kit
CN109884310A (en) Enterobacteriaceae ospa polypeptide, antibody capture device and kit
CN109884309A (en) Enterobacteriaceae polypeptide, antibody capture device and kit
KR101062437B1 (en) Hepatomegaly diagnostic kit comprising hepatitis specific antigen and monoclonal antibodies for the production of said hepatitis specific antigen
CN109884311A (en) Enterobacteria polypeptide, antibody capture device and kit
CA1218299A (en) Antibodies against bacterial peptidoglycans, processes for preparing them and methods of quantitively measuring them
CN109884291A (en) Campylobacter spp polypeptide, antibody capture device and kit
CN109879948A (en) Flagellum polypeptide, antibody capture device and kit
CN109884295A (en) Pseudomonad polypeptide, antibody capture device and kit
CN109879941A (en) Flagellum L polypeptide, antibody capture device and kit
WO2009069942A2 (en) The rapid diagnostic kits for the detection of antibodies against paragonimus westermani and monoclonal antibodies for production of paragonimus westermani-specific antigens
EP0291479A1 (en) Immunoassay method for the diagnosis of chlamydia infection
MATSUNO et al. Antigenic analysis of feline and bovine Chlamydia psittaci with monoclonal antibodies

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant